PlainRecalls
ModerateClass IITerminated

FDA Drug recall · Reported February 12, 2014

Dr. Sheffield Triple Antibiotic Ointment, OTC a) 0.33 oz (9g) (NDC 11527-162-47); b) 1 oz (22g) (NDC 11527-163-55) SHEFFIELD PHARMACEUTICALS, New London, CT 06320

Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testing

Recall #
D-1076-2014
Affected scope
332508
Initiated
November 22, 2013
Verify with FDA Drug →
View my saved recalls

Faria Limited LLC dba Sheffield Pharmaceuticals recalled Dr. Sheffield Triple Antibiotic Ointment, OTC a) 0.33 oz (9g) (NDC 11527-162-47); b) 1 oz… - a moderate-severity action.

Dr. Sheffield Triple Antibiotic Ointment, OTC a) 0.33 oz (9g) (NDC 11527-162-47); b) 1 oz… was recalled by Faria Limited LLC dba Sheffield Pharmaceuticals in February 12, 2014. Reason: Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during envi…. Check the official notice for the remedy. Verify recall #D-1076-2014 with the FDA Drug before acting.

The recall

Faria Limited LLC dba Sheffield Pharmaceuticals issued this moderate-severity FDA Drug recall-Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during envi….

Moderate
severity level
333K units
affected scope
Class II
classification
February 12, 2014
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-1076-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-1076-2014) was formally reported on February 12, 2014, with the manufacturer initiating the action on November 22, 2013. It is classified under Moderate severity (Class II), with a current status of Terminated. Faria Limited LLC dba Sheffield Pharmaceuticals is listed as the recalling firm, operating out of New London, CT. Federal records list the affected scope as 332508, a scale large enough to require multi-state distribution tracking.

The documented reason for this recall is: Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testing Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category - 14,287 drugs & medications recalls on record

-50005001,0001,5002,000 2006201220152018202120242026 263
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

332508

Related Recalls

6

5 from same agency

Product description

Dr. Sheffield Triple Antibiotic Ointment, OTC a) 0.33 oz (9g) (NDC 11527-162-47); b) 1 oz (22g) (NDC 11527-163-55) SHEFFIELD PHARMACEUTICALS, New London, CT 06320

Reason for recall

Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testing

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number D-1076-2014
Date reported February 12, 2014
Date initiated November 22, 2013
Recalling firm Faria Limited LLC dba Sheffield Pharmaceuticals
Firm location New London, CT
Affected scope 332508
Distribution Nationwide

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

Scale of Impact

332508 units affected - multi-state distribution scale.

Regional (<10K units) -
Multi-state (10K – 100K units) -
Large-scale (100K – 1M units) ✓ This recall
Massive (≥1M units) -

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Food and Drug Administration filings.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-1076-2014) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Dr. Sheffield Triple Antibiotic Ointment, OTC a) 0.33 oz (9g) (NDC 11527-162-47); b) 1 oz (22g) (NDC 11527-163-55) SHEFFIELD PHARMACEUTICALS, New London, CT 06320. Recalled by Faria Limited LLC dba Sheffield Pharmaceuticals. Units affected: 332508.
Why was this product recalled?
Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testing
Which agency issued this recall?
This recall was issued by the FDA Drug on February 12, 2014. Severity: Moderate. Recall number: D-1076-2014.
Where was the recalled product distributed?
Distribution: Nationwide.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-1076-2014) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →

Browse all Drugs & Medications recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 12, 2014. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.